NEW YORK (GenomeWeb News) – Researchers have identified a set of 18 SNPs that may explain why some individuals respond better to a widely used multiple sclerosis treatment than others.
Researchers from the University of California, San Francisco, used Affymetrix 100K SNP arrays to identify specific mutations associated with better responses to interferon beta therapy for MS. Their findings appeared yesterday in the online version of Archives of Neurology.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.

Retraction Watch's Ivan Oransky and Adam Marcus report that Harvard Medical School and Brigham and Women's Hospital have recommended that more than 30 papers from a former researcher be retracted.

Thomas Steitz, who won the 2009 chemistry Nobel Prize for his ribosome work, has died, the Washington Post reports.

In PLOS this week: mechanisms for genes implicated in coronary artery disease, rumen microbes and host genetics influence cow methane production, and more.